S&P 500 Futures
(0.20%) 5 142.00 points
Dow Jones Futures
(0.17%) 38 508 points
Nasdaq Futures
(0.27%) 17 894 points
Oil
(-0.31%) $83.59
Gas
(1.98%) $1.961
Gold
(0.10%) $2 349.50
Silver
(0.49%) $27.67
Platinum
(1.05%) $931.80
USD/EUR
(-0.06%) $0.934
USD/NOK
(-0.14%) $11.01
USD/GBP
(-0.19%) $0.799
USD/RUB
(1.45%) $93.20

实时更新: ESSA Pharma Inc [EPIX]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
BUY
100.00%
return 14.09%
SELL
0.00%
return 19.88%
最后更新时间27 Apr 2024 @ 04:00

-0.65% $ 6.08

购买 110362 min ago

@ $9.53

发出时间: 13 Feb 2024 @ 01:36


回报率: -36.20%


上一信号: Feb 9 - 04:49


上一信号: 出售


回报率: -9.50 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):
Profile picture for ESSA Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer...

Stats
今日成交量 178 454
平均成交量 127 423
市值 268.97M
EPS $0 ( 2024-02-13 )
下一个收益日期 ( $-0.190 ) 2024-05-14
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -10.31
ATR14 $0.0430 (0.71%)
Insider Trading
Date Person Action Amount type
2024-04-24 Glickman Richard M Buy 3 750 Common Shares
2024-04-24 Glickman Richard M Sell 3 750 Options
2024-04-05 Virsik Peter Sell 694 Common Shares
2024-03-25 Zweifach Sanford S Buy 50 000 Options
2024-03-25 Thorell Marella Buy 50 000 Options
INSIDER POWER
74.70
Last 100 transactions
Buy: 6 897 304 | Sell: 769 682

音量 相关性

長: -0.05 (neutral)
短: -0.37 (neutral)
Signal:(56.244) Neutral

ESSA Pharma Inc 相关性

10 最正相关
GOODM0.808
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

ESSA Pharma Inc 相关性 - 货币/商品

The country flag 0.14
( neutral )
The country flag 0.22
( neutral )
The country flag 0.00
( neutral )
The country flag -0.03
( neutral )
The country flag 0.09
( neutral )
The country flag -0.14
( neutral )

ESSA Pharma Inc 财务报表

Annual 2023
营收: $0
毛利润: $-118 491 (0.00 %)
EPS: $-0.600
FY 2023
营收: $0
毛利润: $-118 491 (0.00 %)
EPS: $-0.600
FY 2022
营收: $0
毛利润: $-121 787 (0.00 %)
EPS: $-0.800
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.960

Financial Reports:

No articles found.

ESSA Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。